Showing 2680 results
-
Featured News /
Leprosy is an ancient disease that currently infects more than 200 000 people each year. For more than three decades, Novartis and the Novartis Foundation has been working to reduce the incidence of leprosy, and the Novartis Foundation recently helped establish the Global Partnership for Zero Leprosy in an effort to eliminate the disease.
-
Story /
Phil Gotwals talks about his vision for the future of business development for research.
-
Featured News /
COVID-19 is disrupting Africa’s health services – potentially undermining decades of progress on child health.
-
Media Library /
-
Media Library /
-
Media Library /
-
Featured News /
The Corporate Reputation of Pharma 2019 global report reflects the findings of a survey conducted by PatientView with patient organizations worldwide.
-
Press Release /Long-term disability and safety data from ALITHIOS open-label extension study on continuous treatment with Kesimpta vs. later switch from teriflunomide in relapsing multiple sclerosis (RMS) patients…
-
Press Release /Phase III study showed sustained proteinuria reduction at one year with favorable safety1Fabhalta is the only oral alternative complement pathway inhibitor thought to target the underlying cause…
Pagination
- ‹ Previous page
- 1
- …
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- …
- 268
- › Next page